Evidence map›Paper›PMID 28555373›Full record

ReviewJournal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology2017

Blood Brain Barrier Injury in Diabetes: Unrecognized Effects on Brain and Cognition.

Marina Bogush, Nathan A Heldt, Yuri Persidsky

Open access · greenAbstract readReview
In one paragraph

Review in Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 91 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
91citing papers in PubMed, 2 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

91 citing papers in PubMed, 2 syntheses or guidelines pooled it, 163 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Diabetes-Associated Cognitive Impairment: Pathophysiology and Emerging Therapies.Annals of clinical and translational neurology · 2026
    Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Article
  20. Review

31 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Marina BogushDepartment of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, 19140, USA.
Nathan A HeldtDepartment of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, 19140, USA.
Yuri PersidskyDepartment of Pathology and Laboratory Medicine, Temple University Lewis Katz School of Medicine, Philadelphia, PA, 19140, USA. yuri.persidsky@tuhs.temple.edu.
Temple University · US

Funding

Pilot Projects Core (PPC)P30DA013429 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI Munir Gunes Kutlu · 2000 to 2026
$34.6M
BBB Tight Junctions During HIV-1 dementiaR01MH065151 · NIMH · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PERSIDSKY, YURI · 2002 to 2016
$5.9M
CNS injury caused by HIV-1 and alcohol: Protective effects of CB2 activationR37AA015913 · NIAAA · TEMPLE UNIV OF THE COMMONWEALTH · PI PERSIDSKY, YURI · 2010 to 2019
$3.6M
Secoisolariciresinol diglucoside to mitigate inflammation and toxicity in HANDR01MH106967 · NIMH · UNIVERSITY OF PENNSYLVANIA · PI JORDAN-SCIUTTO, KELLY L, PERSIDSKY, YURI · 2015 to 2019
$3.3M
HIV-induced neuroinflammation associated with opioid abuse and tobacco smokeR01DA040619 · NIDA · TEMPLE UNIV OF THE COMMONWEALTH · PI PERSIDSKY, YURI, ROGERS, THOMAS J · 2016 to 2020
$3.2M
Novel CB2 agonists shield brain from HIV infection and alcohol exposureU01AA023552 · NIAAA · TEMPLE UNIV OF THE COMMONWEALTH · PI PERSIDSKY, YURI · 2016 to 2020
$1.8M
PPAR-gamma-mediated neuroprotection against HIV-1 and alcohol CNS injuryR01AA015913 · NIAAA · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI PERSIDSKY, YURI · 2005 to 2009
$1.6M
National Institute of Mental Health MH106967National Institute of Mental Health MH65151National Institute on Alcohol Abuse and Alcoholism AA015913National Institute on Drug Abuse DA013429NIAAA NIH HHS R01 AA015913NIAAA NIH HHS R37 AA015913NIAAA NIH HHS U01 AA023552NIDA NIH HHS P30 DA013429NIDA NIH HHS R01 DA040619NIMH NIH HHS R01 MH065151NIMH NIH HHS R01 MH106967
6 · The paper itself

Abstract

Diabetes mellitus (DM) is a disorder due to the inability properly to metabolize glucose associated with dysregulation of metabolic pathways of lipids and proteins resulting in structural and functional changes of various organ systems. DM has detrimental effects on the vasculature, resulting in the development of various cardiovascular diseases and stemming from microvascular injury. The blood brain barrier (BBB) is a highly specialized structure protecting the unique microenvironment of the brain. Endothelial cells, connected by junctional complexes and expressing numerous transporters, constitute the main cell type in the BBB. Other components, including pericytes, basement membrane, astrocytes and perivascular macrophages, join endothelial cells to form the neurovascular unit (NVU) and contribute to the proper function and integrity of the BBB. The role of the BBB in the pathogenesis of diabetic encephalopathy and other diabetes-related complications in the central nervous system is apparent. However, the mechanisms, timing and consequences of BBB injury in diabetes are not well understood. The importance of further studies related to barrier dysfunction in diabetes is dictated by its potential involvement in the cognitive demise associated with DM. This review summarizes the impact of DM on BBB/NVU integrity and function leading to neurological and cognitive complications.

Indexed as

Blood-Brain BarrierBrainCognitionCognition DisordersDiabetes ComplicationsDiabetes MellitusHumansBlood brain barrierCognitive impairmentDiabetesEndothelial cellNeuroinflammationPericyte

Identifiers

PMID28555373
PMCPMC5693692
OpenAlexW2620222982

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.